This European Respiratory Society/Thoracic Society of Australia and New Zealand statement outlines a review of the literature and expert opinion concerning the management of reproduction and pregnancy in women with airways diseases: asthma, cystic fibrosis (CF) and non-CF bronchiectasis. Many women with these diseases are now living into reproductive age, with some developing moderate-to-severe impairment of lung function in early adulthood. The statement covers aspects of fertility, management during pregnancy, effects of drugs, issues during delivery and the post-partum period, and patients’ views about family planning, pregnancy and parenthood. The statement summarises current knowledge and proposes topics for future research, but does not make specific clinical recommendations. Good management of women with airways diseases before, during and after pregnancy is an important area of respiratory medicine, affecting both the mother and child: a statement from the ERS and TSANZ http://bit.ly/2mMwvGZ

中文翻译：

---

ERS/TSANZ 工作组关于气道疾病妇女生殖和妊娠管理的声明

这份欧洲呼吸学会/澳大利亚和新西兰胸科学会的声明概述了对患有气道疾病的女性生殖和妊娠管理的文献和专家意见的回顾：哮喘、囊性纤维化 (CF) 和非 CF 支气管扩张。许多患有这些疾病的女性现在已经活到生育年龄，有些女性在成年早期会出现中度至重度的肺功能损害。该声明涵盖生育、孕期管理、药物影响、分娩和产后问题以及患者对计划生育、怀孕和为人父母的看法等方面。该声明总结了当前的知识并提出了未来研究的主题，但没有提出具体的临床建议。之前对患有气道疾病的女性进行良好管理，